NewslettersHepatic Cell NewsCD8 Cis-Targeted IL-2 Drives Potent Antiviral Activity Against Hepatitis B VirusBy Jamie Kang - January 17, 20240257Scientists developed a cis-targeted CD8-interleukin-2 fusion protein, aiming to selectively stimulate dysfunctional CD8+ T cells in chronic hepatitis B virus.[Science Translational Medicine]Abstract